These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19896824)

  • 41. Introduction to gene technology.
    Ritschel WA; Forusz H
    Methods Find Exp Clin Pharmacol; 1994 Sep; 16(7):453-67. PubMed ID: 7885071
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The 6th world meeting on pharmaceutics, biopharmaceutics and pharmaceutical technology (PBP meeting) April 7-10, 2008, Barcelona, Spain.
    Kleinebudde P; Alex R; Fattal E; Göpferich A; Siepmann J
    AAPS PharmSciTech; 2008; 9(3):828. PubMed ID: 18618267
    [No Abstract]   [Full Text] [Related]  

  • 43. Biopharmaceuticals derived from genetically modified plants.
    Goldstein DA; Thomas JA
    QJM; 2004 Nov; 97(11):705-16. PubMed ID: 15496527
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chromatography-free recovery of biopharmaceuticals through aqueous two-phase processing.
    Azevedo AM; Rosa PA; Ferreira IF; Aires-Barros MR
    Trends Biotechnol; 2009 Apr; 27(4):240-7. PubMed ID: 19251328
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Minimizing immunogenicity of biopharmaceuticals by controlling critical quality attributes of proteins.
    van Beers MM; Bardor M
    Biotechnol J; 2012 Dec; 7(12):1473-84. PubMed ID: 23027660
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Electrochemical parameters and techniques in drug development, with an emphasis on quinones and related compounds.
    Hillard EA; de Abreu FC; Ferreira DC; Jaouen G; Goulart MO; Amatore C
    Chem Commun (Camb); 2008 Jun; (23):2612-28. PubMed ID: 18535688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular modeling of hydration in drug design.
    Mancera RL
    Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles.
    Muller RH; Keck CM
    J Biotechnol; 2004 Sep; 113(1-3):151-70. PubMed ID: 15380654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
    Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
    Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
    Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physics-based methods for studying protein-ligand interactions.
    Huang N; Jacobson MP
    Curr Opin Drug Discov Devel; 2007 May; 10(3):325-31. PubMed ID: 17554859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Guest editors' note: special issue on recent developments in statistical approaches for chemistry and manufacturing control (CMC) and quality-by-design(QbD).
    Tsong Y; Yang H
    J Biopharm Stat; 2015; 25(2):233. PubMed ID: 25437635
    [No Abstract]   [Full Text] [Related]  

  • 53. An Intercompany Perspective on Biopharmaceutical Drug Product Robustness Studies.
    Morar-Mitrica S; Adams ML; Crotts G; Wurth C; Ihnat PM; Tabish T; Antochshuk V; DiLuzio W; Dix DB; Fernandez JE; Gupta K; Fleming MS; He B; Kranz JK; Liu D; Narasimhan C; Routhier E; Taylor KD; Truong N; Stokes ESE
    J Pharm Sci; 2018 Feb; 107(2):529-542. PubMed ID: 29074375
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Continuous bioprocessing: the real thing this time? 10(th) Annual bioProcessUK Conference, December 3-4, 2013, London, UK.
    Farid SS; Thompson B; Davidson A
    MAbs; 2014; 6(6):1357-61. PubMed ID: 25484060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Editorial overview: pharmaceutical biotechnology: engineering cells for high quality biopharmaceuticals production.
    Junker BH; Young JD
    Curr Opin Biotechnol; 2014 Dec; 30():viii-x. PubMed ID: 25459164
    [No Abstract]   [Full Text] [Related]  

  • 56. Drug Discovery Technology 2003--seventh annual conference and exhibition. Science, business and IT for drug discovery I. 31 March-3 April 2003, Stuttgart, Germany.
    Mackonochie M
    IDrugs; 2003 May; 6(5):417-9. PubMed ID: 12841199
    [No Abstract]   [Full Text] [Related]  

  • 57. Rational design and optimization of downstream processes of virus particles for biopharmaceutical applications: current advances.
    Vicente T; Mota JP; Peixoto C; Alves PM; Carrondo MJ
    Biotechnol Adv; 2011; 29(6):869-78. PubMed ID: 21784144
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug Discovery Technology 2003--seventh annual conference and exhibition. Science, business and IT for drug discovery II. 31 March-3 April 2003, Stuttgart, Germany.
    Mackonochie M
    IDrugs; 2003 May; 6(5):420-2. PubMed ID: 12841200
    [No Abstract]   [Full Text] [Related]  

  • 59. Current Challenges and Potential Opportunities for the Pharmaceutical Sciences to Make Global Impact: An FIP Perspective.
    Tucker G; DeSilva B; Dressman J; Ito M; Kumamoto T; Mager D; Mahler HC; Maitland-van der Zee AH; Pauletti GM; Sasaki H; Shah V; Tang D; Ward M
    J Pharm Sci; 2016 Sep; 105(9):2489-2497. PubMed ID: 26886325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imaging tools for pharmaceutical development.
    Gurny R; Mäder K
    Eur J Pharm Biopharm; 2010 Jan; 74(1):1. PubMed ID: 19919848
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.